查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945428

2026年全球体外诊断设备市场报告

In-Vitro Diagnostics Instruments Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，体外诊断设备市场成长显着，预计将以10.0%的复合年增长率从2025年的610.9亿美元成长到2026年的671.8亿美元。过去几年的成长可归因于慢性病盛行率上升、医院检查室基础设施扩建、诊断剂技术进步、早期疾病检测意识提升以及政府医疗保健政策等因素。

预计未来几年体外诊断市场将快速成长，到2030年市场规模将达到994.4亿美元，复合年增长率（CAGR）为10.3%。预测期内的成长要素包括分子诊断技术的进步、个人化医疗的扩展、人工智慧在诊断领域的应用、新兴市场医疗保健的扩张以及对家用诊断设备的需求。预测期内的主要趋势包括就地检验的普及、个人化诊断的推广、快速分子检测的广泛应用、远端患者监护的整合以及小型化检测设备的出现。

慢性病和文明病的日益普遍预计将在未来几年推动体外诊断市场的成长。慢性病和文明病是指主要受日常习惯、行为和环境因素影响的长期健康状况（例如心臟病、糖尿病、肥胖症和某些癌症）。由于久坐不动的生活方式和不健康的饮食习惯，这些疾病的发生率正在上升。随着慢性病和文明病的日益普遍，企业致力于应用早期检测和监测工具来改善疾病管理，这推动了对体外诊断的需求不断增长。例如，根据总部位于美国的非营利中间偏右智库「美国行动论坛」（American Action Forum）称，截至2024年，慢性病已成为美国一项重大的公共卫生问题，约60%的成年人患有至少一种慢性病，40%的成年人患有多种慢性病，预计到2050年，这一患病率将几乎翻一番。此外，慢性病治疗市场预计将从2025年的97.4亿美元成长到2034年的约380.2亿美元。因此，慢性病和文明病的日益增加正在推动体外诊断设备市场的成长。

体外诊断市场的主要企业正致力于开发先进技术，例如数位聚合酵素链锁反应(dPCR) 系统，以实现高精度、高灵敏度的核酸定量，从而推动下一代诊断的发展。数位聚合酵素链锁反应(dPCR) 系统是一种先进的诊断设备，它透过将样本分成数千个独立的反应来定量 DNA 或 RNA 分子，从而实现卓越的检测准确性和灵敏度。例如，总部位于荷兰的生物技术公司 QIAGEN NV 于 2024 年 9 月推出了 QIAcuityDx 数位 PCR 系统，将其 dPCR 产品组合扩展到临床诊断领域，主要专注于肿瘤检测。这款完全整合、自动化的系统专为临床应用而设计，其基于试剂盒的工作流程最大限度地减少了人工操作。 QIAcuityDx 配备了自动化分析和报告软体，能够快速且准确地检测用于癌症诊断和治疗监测的遗传生物标记物，在确保结果可靠且可重复的同时，减少操作人员的参与。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球体外诊断设备市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 人工智慧（AI）和自主人工智慧
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 扩大即时检测范围
    • 个性化诊断
    • 扩大快速分子检测的应用
    • 远端患者监护集成
    • 小型化实验室设备

第五章 终端用户产业市场分析

  • 医院
  • 诊断检查室
  • 学术和研究机构
  • 血库
  • 製药和生物技术公司

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球体外诊断设备市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球体外诊断设备市场规模、对比及成长率分析
  • 全球体外诊断设备市场表现：规模与成长，2020-2025年
  • 全球体外诊断设备市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场总量（TAM）

第九章 市场细分

  • 依产品类型
  • 临床化学、免疫检测、分子诊断、血液学、微生物学、凝血、其他产品类型
  • 透过使用
  • 感染疾病、癌症、心臟病学、肾臟病学、自体免疫疾病及其他应用领域
  • 最终用户
  • 医院和诊断检查室、学术研究机构、照护现场、血库、製药和生物技术公司以及其他医疗机构
  • 按类型细分：临床化学
  • 全自动临床化学分析仪、半全自动临床化学分析仪、照护现场临床化学分析仪
  • 按类型细分：免疫检测
  • 酵素免疫分析法（ELISA）系统、化学冷光免疫检测（CLIA）分析仪、免疫检测（RIA）系统
  • 按类型细分：分子诊断
  • 聚合酵素链锁反应（PCR）系统、次世代定序（NGS）平台、去氧核糖核酸微阵列、等温扩增装置
  • 按类型细分：血液学
  • 自动血液分析仪、手动血液分析仪、止血分析仪、凝血分析仪
  • 按类型细分：微生物学
  • 微生物鑑定係统、抗菌药物敏感性试验（AST）系统、血液培养系统、自动化微生物分析仪
  • 按类型细分：凝血
  • 凝血测量设备、血小板功能分析仪、血栓弹性图（TEG）系统、照护现场凝血测量设备
  • 按类型细分：其他产品类型
  • 照护现场诊断设备和其他检测设备

第十章 区域与国家分析

  • 全球体外诊断设备市场：区域分析、预测与趋势，2020-2025年、2025-2030年预测、2035年预测
  • 全球体外诊断设备市场：国家、绩效及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 体外诊断设备市场：竞争格局及市场占有率（2024年）
  • 体外诊断设备市场：公司估值矩阵
  • 体外诊断设备市场：公司概况
    • F. Hoffmann-La Roche Ltd
    • Danaher Corporation
    • Abbott Laboratories
    • Thermo Fisher Scientific
    • Siemens Healthineers AG

第37章：其他领先和创新企业

  • Becton Dickinson and Company, Sysmex Corporation, Bio-Rad Laboratories Inc, Agilent Technologies, Hologic Inc, Qiagen NV, Illumina Inc, Ortho Clinical Diagnostics, Beckman Coulter Inc, Mindray Medical International Limited, Horiba Ltd, Randox Laboratories Ltd, DiaSorin SpA, Werfen SA, Trinity Biotech plc

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年体外诊断设备市场：提供新机会的国家
  • 2030年体外诊断设备市场：充满新机会的细分市场
  • 2030年体外诊断设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME3MIVDI04_G26Q1

In-vitro diagnostic instruments are medical devices used to analyze biological samples, such as blood, urine, or tissue, outside the human body. Their primary function is to detect, diagnose, monitor, and manage diseases or medical conditions by providing accurate and timely laboratory test results. These instruments aid clinical decision-making and support personalized patient care.

The primary product types of in-vitro diagnostic instruments include clinical chemistry, immunoassay, molecular diagnostics, hematology, microbiology, coagulation, and others. Clinical chemistry instruments are digital tools, often leveraging AI, to analyze blood, urine, and other body fluids, helping identify biochemical abnormalities, improve diagnostic accuracy, and guide treatment planning. These instruments are applied across multiple areas, including infectious diseases, cancer, cardiology, nephrology, and autoimmune disorders. They serve a diverse range of end users, including hospitals, diagnostic laboratories, academic and research institutes, point-of-care facilities, blood banks, and pharmaceutical and biotechnology companies.

Tariffs are impacting the in-vitro diagnostics instruments market by increasing costs of imported reagents, analyzers, and precision components, particularly affecting molecular diagnostics and clinical chemistry segments. Asia-Pacific manufacturing hubs such as China and India are most impacted, causing supply chain disruptions and higher device prices. However, tariffs are encouraging local manufacturing investments, which could improve domestic production capabilities and reduce long-term dependency on imports.

The in-vitro diagnostics instruments market research report is one of a series of new reports from The Business Research Company that provides in-vitro diagnostics instruments market statistics, including in-vitro diagnostics instruments industry global market size, regional shares, competitors with a in-vitro diagnostics instruments market share, detailed in-vitro diagnostics instruments market segments, market trends and opportunities, and any further data you may need to thrive in the in-vitro diagnostics instruments industry. This in-vitro diagnostics instruments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in-vitro diagnostics instruments market size has grown strongly in recent years. It will grow from $61.09 billion in 2025 to $67.18 billion in 2026 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing hospital lab infrastructure, advances in diagnostic reagents, growing awareness for early disease detection, government healthcare initiatives.

The in-vitro diagnostics instruments market size is expected to see rapid growth in the next few years. It will grow to $99.44 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to technological advancements in molecular diagnostics, growth of personalized medicine, integration of AI in diagnostics, expansion of emerging markets healthcare, demand for home-based diagnostic devices. Major trends in the forecast period include point-of-care testing expansion, personalized diagnostics, rapid molecular testing adoption, remote patient monitoring integration, miniaturized lab instruments.

The rising prevalence of chronic and lifestyle related diseases is expected to enhance the growth of the in vitro diagnostics instruments market in the coming years. Chronic and lifestyle related diseases refer to long term health conditions primarily influenced by daily habits, behaviors, and environmental factors, such as heart disease, diabetes, obesity, and certain cancers. The incidence of these diseases is increasing due to sedentary lifestyles and unhealthy dietary habits. In vitro diagnostics instruments are experiencing higher demand as the growing burden of chronic and lifestyle related diseases encourages companies to adopt early detection and monitoring tools for improved disease management. For example, in 2024, according to the American Action Forum, a U.S. based non profit, center right think tank, chronic diseases remain a major public health concern in the United States, with nearly 60 percent of adults living with at least one condition, 40 percent managing multiple conditions, and prevalence expected to nearly double by 2050. Furthermore, the chronic disease treatment market is projected to reach approximately 38.02 billion dollars by 2034, up from 9.74 billion dollars in 2025. Therefore, the rising prevalence of chronic and lifestyle related diseases is enhancing the growth of the in vitro diagnostics instruments market.

Prominent companies operating in the in-vitro diagnostics instruments market are focusing on developing advanced technologies, such as digital polymerase chain reaction (dPCR) systems, to achieve highly precise and sensitive nucleic acid quantification for next-generation diagnostics. Digital polymerase chain reaction (dPCR) systems are sophisticated diagnostic instruments that quantify DNA or RNA molecules by dividing samples into thousands of individual reactions, allowing for exceptional accuracy and sensitivity in detection. For example, in September 2024, QIAGEN N.V., a Netherlands-based biotechnology company, introduced the QIAcuityDx Digital PCR System, expanding its dPCR portfolio into clinical diagnostics with a primary focus on oncology testing. This fully integrated and automated system is specifically designed for clinical use, featuring a cartridge-based workflow that minimizes manual handling. Equipped with automated analysis and reporting software, the QIAcuityDx enables rapid and precise detection of genetic biomarkers for cancer diagnosis and therapy monitoring, reducing operator involvement while ensuring reliable and reproducible results.

In January 2025, Fremman Ltd., a UK-based investment company, acquired a majority stake in DIESSE Diagnostica Senese S.p.A. for an undisclosed amount. Through this acquisition, Fremman Ltd aims to expand DIESSE Diagnostica Senese's international presence, strengthen its leadership in specialty in vitro diagnostics, and support ongoing innovation to advance global diagnostic capabilities and improve patient outcomes. DIESSE Diagnostica Senese S.p.A. is an Italy-based medical equipment company that provides in vitro diagnostic instruments.

Major companies operating in the in-vitro diagnostics instruments market are F. Hoffmann-La Roche Ltd, Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers AG, Becton Dickinson and Company, Sysmex Corporation, Bio-Rad Laboratories Inc, Agilent Technologies, Hologic Inc, Qiagen N.V., Illumina Inc, Ortho Clinical Diagnostics, Beckman Coulter Inc, Mindray Medical International Limited, Horiba Ltd, Randox Laboratories Ltd, DiaSorin S.p.A., Werfen S.A., Trinity Biotech plc

North America was the largest region in the in-vitro diagnostics instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro diagnostics instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in-vitro diagnostics instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The in-vitro diagnostics instruments market consists of sales of point-of-care testing devices, flow cytometry instruments, histopathology and cytology instruments, and molecular point-of-care systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In-Vitro Diagnostics Instruments Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses in-vitro diagnostics instruments market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in-vitro diagnostics instruments ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in-vitro diagnostics instruments market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Clinical Chemistry; Immunoassay; Molecular Diagnostics; Hematology; Microbiology; Coagulation; Other Product Types
  • 2) By Application: Infectious Diseases; Cancer; Cardiology; Nephrology; Autoimmune Diseases; Other Applications
  • 3) By End User: Hospitals And Diagnostic Laboratories; Academic And Research Institutes; Point-Of-Care Settings; Blood Banks; Pharmaceutical And Biotechnology Companies; Other Healthcare Facilities
  • Subsegments:
  • 1) By Clinical Chemistry: Automated Clinical Chemistry Analyzers; Semi-Automated Clinical Chemistry Analyzers; Point-Of-Care Clinical Chemistry Devices
  • 2) By Immunoassay: Enzyme-Linked Immunosorbent Assay (ELISA) Systems; Chemiluminescence Immunoassay (CLIA) Analyzers; Radioimmunoassay (RIA) Systems
  • 3) By Molecular Diagnostics: Polymerase Chain Reaction (PCR) Systems; Next-Generation Sequencing (NGS) Platforms; Deoxyribonucleic Acid Microarrays; Isothermal Amplification Devices
  • 4) By Hematology: Automated Hematology Analyzers; Manual Hematology Analyzers; Hemostasis Analyzers; Coagulation Analyzers
  • 5) By Microbiology: Microbial Identification Systems; Antibiotic Susceptibility Testing (AST) Systems; Blood Culture Systems; Automated Microbial Analyzers.
  • 6) By Coagulation: Coagulometers; Platelet Function Analyzers; Thromboelastography (TEG) Systems; Point-Of-Care Coagulation Devices
  • 7) By Other Product Types: Point-Of-Care Diagnostic Devices; Miscellaneous Laboratory Instruments
  • Companies Mentioned: F. Hoffmann-La Roche Ltd; Danaher Corporation; Abbott Laboratories; Thermo Fisher Scientific; Siemens Healthineers AG; Becton Dickinson and Company; Sysmex Corporation; Bio-Rad Laboratories Inc; Agilent Technologies; Hologic Inc; Qiagen N.V.; Illumina Inc; Ortho Clinical Diagnostics; Beckman Coulter Inc; Mindray Medical International Limited; Horiba Ltd; Randox Laboratories Ltd; DiaSorin S.p.A.; Werfen S.A.; Trinity Biotech plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. In-Vitro Diagnostics Instruments Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global In-Vitro Diagnostics Instruments Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. In-Vitro Diagnostics Instruments Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global In-Vitro Diagnostics Instruments Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Point-Of-Care Testing Expansion
    • 4.2.2 Personalized Diagnostics
    • 4.2.3 Rapid Molecular Testing Adoption
    • 4.2.4 Remote Patient Monitoring Integration
    • 4.2.5 Miniaturized Lab Instruments

5. In-Vitro Diagnostics Instruments Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Laboratories
  • 5.3 Academic & Research Institutes
  • 5.4 Blood Banks
  • 5.5 Pharmaceutical & Biotechnology Companies

6. In-Vitro Diagnostics Instruments Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global In-Vitro Diagnostics Instruments Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global In-Vitro Diagnostics Instruments PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global In-Vitro Diagnostics Instruments Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global In-Vitro Diagnostics Instruments Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global In-Vitro Diagnostics Instruments Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global In-Vitro Diagnostics Instruments Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. In-Vitro Diagnostics Instruments Market Segmentation

  • 9.1. Global In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Clinical Chemistry, Immunoassay, Molecular Diagnostics, Hematology, Microbiology, Coagulation, Other Product Types
  • 9.2. Global In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Infectious Diseases, Cancer, Cardiology, Nephrology, Autoimmune Diseases, Other Applications
  • 9.3. Global In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Point-Of-Care Settings, Blood Banks, Pharmaceutical And Biotechnology Companies, Other Healthcare Facilities
  • 9.4. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Clinical Chemistry, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Automated Clinical Chemistry Analyzers, Semi-Automated Clinical Chemistry Analyzers, Point-Of-Care Clinical Chemistry Devices
  • 9.5. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Immunoassay, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Enzyme-Linked Immunosorbent Assay (ELISA) Systems, Chemiluminescence Immunoassay (CLIA) Analyzers, Radioimmunoassay (RIA) Systems
  • 9.6. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Molecular Diagnostics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR) Systems, Next-Generation Sequencing (NGS) Platforms, Deoxyribonucleic Acid Microarrays, Isothermal Amplification Devices
  • 9.7. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Hematology, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Automated Hematology Analyzers, Manual Hematology Analyzers, Hemostasis Analyzers, Coagulation Analyzers
  • 9.8. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Microbiology, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Microbial Identification Systems, Antibiotic Susceptibility Testing (AST) Systems, Blood Culture Systems, Automated Microbial Analyzers
  • 9.9. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Coagulation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Coagulometers, Platelet Function Analyzers, Thromboelastography (TEG) Systems, Point-Of-Care Coagulation Devices
  • 9.10. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Point-Of-Care Diagnostic Devices, Miscellaneous Laboratory Instruments

10. In-Vitro Diagnostics Instruments Market Regional And Country Analysis

  • 10.1. Global In-Vitro Diagnostics Instruments Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global In-Vitro Diagnostics Instruments Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific In-Vitro Diagnostics Instruments Market

  • 11.1. Asia-Pacific In-Vitro Diagnostics Instruments Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China In-Vitro Diagnostics Instruments Market

  • 12.1. China In-Vitro Diagnostics Instruments Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India In-Vitro Diagnostics Instruments Market

  • 13.1. India In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan In-Vitro Diagnostics Instruments Market

  • 14.1. Japan In-Vitro Diagnostics Instruments Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia In-Vitro Diagnostics Instruments Market

  • 15.1. Australia In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia In-Vitro Diagnostics Instruments Market

  • 16.1. Indonesia In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea In-Vitro Diagnostics Instruments Market

  • 17.1. South Korea In-Vitro Diagnostics Instruments Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan In-Vitro Diagnostics Instruments Market

  • 18.1. Taiwan In-Vitro Diagnostics Instruments Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia In-Vitro Diagnostics Instruments Market

  • 19.1. South East Asia In-Vitro Diagnostics Instruments Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe In-Vitro Diagnostics Instruments Market

  • 20.1. Western Europe In-Vitro Diagnostics Instruments Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK In-Vitro Diagnostics Instruments Market

  • 21.1. UK In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany In-Vitro Diagnostics Instruments Market

  • 22.1. Germany In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France In-Vitro Diagnostics Instruments Market

  • 23.1. France In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy In-Vitro Diagnostics Instruments Market

  • 24.1. Italy In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain In-Vitro Diagnostics Instruments Market

  • 25.1. Spain In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe In-Vitro Diagnostics Instruments Market

  • 26.1. Eastern Europe In-Vitro Diagnostics Instruments Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia In-Vitro Diagnostics Instruments Market

  • 27.1. Russia In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America In-Vitro Diagnostics Instruments Market

  • 28.1. North America In-Vitro Diagnostics Instruments Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA In-Vitro Diagnostics Instruments Market

  • 29.1. USA In-Vitro Diagnostics Instruments Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada In-Vitro Diagnostics Instruments Market

  • 30.1. Canada In-Vitro Diagnostics Instruments Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America In-Vitro Diagnostics Instruments Market

  • 31.1. South America In-Vitro Diagnostics Instruments Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil In-Vitro Diagnostics Instruments Market

  • 32.1. Brazil In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East In-Vitro Diagnostics Instruments Market

  • 33.1. Middle East In-Vitro Diagnostics Instruments Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa In-Vitro Diagnostics Instruments Market

  • 34.1. Africa In-Vitro Diagnostics Instruments Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. In-Vitro Diagnostics Instruments Market Regulatory and Investment Landscape

36. In-Vitro Diagnostics Instruments Market Competitive Landscape And Company Profiles

  • 36.1. In-Vitro Diagnostics Instruments Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. In-Vitro Diagnostics Instruments Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. In-Vitro Diagnostics Instruments Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

37. In-Vitro Diagnostics Instruments Market Other Major And Innovative Companies

  • Becton Dickinson and Company, Sysmex Corporation, Bio-Rad Laboratories Inc, Agilent Technologies, Hologic Inc, Qiagen N.V., Illumina Inc, Ortho Clinical Diagnostics, Beckman Coulter Inc, Mindray Medical International Limited, Horiba Ltd, Randox Laboratories Ltd, DiaSorin S.p.A., Werfen S.A., Trinity Biotech plc

38. Global In-Vitro Diagnostics Instruments Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The In-Vitro Diagnostics Instruments Market

40. In-Vitro Diagnostics Instruments Market High Potential Countries, Segments and Strategies

  • 40.1 In-Vitro Diagnostics Instruments Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 In-Vitro Diagnostics Instruments Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 In-Vitro Diagnostics Instruments Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer